Companies: 10,795·Total market cap: $144.5T
Canopus BioPharma Incorporated

Canopus BioPharma Incorporated

CBIAOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$455071
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Overview

Canopus BioPharma Incorporated (CBIA) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CBIA · earnings · updated Jun 8, 2026

No earnings history available.

Next Earnings Date

Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
No earnings history available.

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q4 FY2024$1.54$1.54$1.541
Q3 FY2024$1.34$1.34$1.341
Q2 FY2024$1.57$1.57$1.571
Q1 FY2024$2.09$2.09$2.091
Q4 FY2023$1.39$1.39$1.391
Q3 FY2023$1.19$1.19$1.191
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q4 FY2024$0.0B$0.0B$0.0B0
Q3 FY2024$0.0B$0.0B$0.0B0
Q2 FY2024$0.0B$0.0B$0.0B0
Q1 FY2024$0.0B$0.0B$0.0B0
Q4 FY2023$0.0B$0.0B$0.0B0
Q3 FY2023$0.0B$0.0B$0.0B0

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: CBIA ends December

Canopus BioPharma Incorporated (CBIA) reports earnings quarterly as a OTC-listed Shell Companies company. The next CBIA earnings date is expected around September 1, 2026.

Each quarter, investors track CBIA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBIA revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBIA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

CBIA earnings · 3 questions

Canopus BioPharma Incorporated's next earnings report is expected around September 1, 2026. CBIA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBIA historically reports after market close (AMC).

CBIA earnings datewhen is CBIA earningsCBIA next earnings datewhen does CBIA report earningsCBIA earnings calendar

▸ Source: FMP · Canopus BioPharma Incorporated SEC filings · US GAAP · Canopus BioPharma Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026